Abstract
Patients with aspirin exacerbated respiratory disease (AERD) frequently present with severe chronic rhinosinusitis with nasal polyposis (CRSwNP). Prior work by our group has identified potential inflammatory subtypes of AERD in patients using mucus-derived lipid biomarkers. In this study, we hypothesized that these biomarkers could be used to non-invasively diagnose AERD.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
